{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:04:22Z","timestamp":1794650662265,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA014089\\u201345"],"award-info":[{"award-number":["5P30CA014089\\u201345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA248381\\u201301A1"],"award-info":[{"award-number":["1R01CA248381\\u201301A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30"],"award-info":[{"award-number":["P30"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004165","name":"Stop! Children's Cancer of Palm Beach County","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009412","name":"School of Pharmacy, University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113000","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:48:21Z","timestamp":1651214901000},"page":"113000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"150","author":[{"given":"Sharon","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Bhojwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Alachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2022.113000_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"issue":"14","key":"10.1016\/j.biopha.2022.113000_bib2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children\u2019s oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"27","key":"10.1016\/j.biopha.2022.113000_bib3","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13643-021-01588-7","article-title":"Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: A protocol for a systematic review and meta-analysis","volume":"10","author":"Adeel","year":"2021","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2022.113000_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.26156","article-title":"Acute lymphoblastic leukemia: A population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017","volume":"96","author":"Sasaki","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113000_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26891","article-title":"Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens","volume":"65","author":"Denton","year":"2018","journal-title":"Pedia Blood Cancer"},{"issue":"20","key":"10.1016\/j.biopha.2022.113000_bib7","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","article-title":"Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-Acute lymphoblastic leukemia: A report from children\u2019s oncology group study AALL0232","volume":"34","author":"Larsen","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113000_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.biopha.2022.113000_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A pediatric oncology group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.biopha.2022.113000_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2006-06-027714","article-title":"Results of the dana-farber cancer institute all consortium protocol 95-01 for children with acute lymphoblastic leukemia","volume":"109","author":"Moghrabi","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biopha.2022.113000_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3109\/10428194.2011.596963","article-title":"Prevention and management of asparaginase\/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel","volume":"52","author":"Stock","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.biopha.2022.113000_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3109\/10428194.2015.1101098","article-title":"Asparaginase-associated toxicity in children with acute lymphoblastic leukemia","volume":"57","author":"Hijiya","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"17","key":"10.1016\/j.biopha.2022.113000_bib13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: A report from the children\u2019s oncology group","volume":"38","author":"Gupta","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2022.113000_bib14","first-page":"4281","article-title":"Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia [published online ahead of print, 2021 Sep 16]","author":"Schulte","year":"2021","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.biopha.2022.113000_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26871","article-title":"An investigation of toxicities and survival in Hispanic children and adolescents with all: Results from the dana-farber cancer institute all consortium protocol 05-001","volume":"65","author":"Kahn","year":"2018","journal-title":"Pedia Blood Cancer"},{"issue":"17","key":"10.1016\/j.biopha.2022.113000_bib16","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/cncr.30089","article-title":"Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma","volume":"122","author":"Kahn","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2022.113000_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1078155217701291","article-title":"Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen","volume":"24","author":"Christ","year":"2018","journal-title":"J. Oncol. Pharm. Pr."},{"issue":"15_suppl","key":"10.1016\/j.biopha.2022.113000_bib18","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.e18051","article-title":"Impact of body mass index and ethnicity on asparaginase toxicity in adult acute lymphoblastic leukemia patients","volume":"33","author":"Law","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113000_bib19","first-page":"274","article-title":"Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia","volume":"17","author":"Alachkar","year":"2017","journal-title":"Pharm. J."},{"issue":"9","key":"10.1016\/j.biopha.2022.113000_bib20","doi-asserted-by":"crossref","first-page":"E1124","DOI":"10.1152\/ajpendo.00080.2013","article-title":"The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment","volume":"305","author":"Wilson","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2022.113000_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2217\/14622416.7.4.613","article-title":"The role of genetic variability in drug metabolism pathways in breast cancer prognosis","volume":"7","author":"Choi","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.biopha.2022.113000_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng1295-376","article-title":"Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase","volume":"11","author":"Li","year":"1995","journal-title":"Nat. Genet"},{"issue":"18","key":"10.1016\/j.biopha.2022.113000_bib23","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1073\/pnas.93.18.9782","article-title":"Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice","volume":"93","author":"Lebovitz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.23668","article-title":"Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury","volume":"52","author":"Lucena","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2022.113000_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mpo.10161","article-title":"SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia","volume":"39","author":"McNeil","year":"2002","journal-title":"Med Pedia Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113000_bib27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1070::AID-CNCR25>3.0.CO;2-9","article-title":"Cancer among Hispanic children in California, 1988-1994: Comparison with non-Hispanic white children","volume":"86","author":"Glazer","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S1020-49892005000600002","article-title":"Cancer incidence among Hispanic children in the United States","volume":"18","author":"Wilkinson","year":"2005","journal-title":"Rev. Panam. Salud Publica"},{"issue":"9","key":"10.1016\/j.biopha.2022.113000_bib29","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/cncr.11316","article-title":"Trends in leukemia incidence and survival in the United States (1973-1998) [published correction appears in Cancer. 2993 Aug 1;98(3):659]","volume":"97","author":"Xie","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2022.113000_bib30","unstructured":"SAS Program ( ages 0 to < 20 years) | Resources | Growth Chart Training | Nutrition | DNPAO | CDC. www.cdc.gov. Published February 26, 2019. \u3008https:\/\/www.cdc.gov\/nccdphp\/dnpao\/growthcharts\/resources\/sas.htm\u3009."},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cpt.629","article-title":"Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy","volume":"102","author":"Liu","year":"2017","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2022.113000_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fphar.2020.00324","article-title":"The identification of admixture patterns could refine pharmacogenetic counseling: Analysis of a population-based sample in Mexico","volume":"11","author":"Mart\u00ednez-Maga\u00f1a","year":"2020","journal-title":"Front Pharmacol."},{"issue":"6189","key":"10.1016\/j.biopha.2022.113000_bib33","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1126\/science.1251688","article-title":"Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits","volume":"344","author":"Moreno-Estrada","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2022.113000_bib34","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1038\/s41598-021-03208-9","article-title":"Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol","volume":"11","author":"Aslam","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2022.113000_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3121","article-title":"A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population","volume":"21","author":"Wu","year":"2019","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2022.113000_bib36","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: Harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"issue":"15","key":"10.1016\/j.biopha.2022.113000_bib37","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2006.07.7792","article-title":"Obesity and outcome in pediatric acute lymphoblastic leukemia","volume":"25","author":"Butturini","year":"2007","journal-title":"J. Clin. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:30:27Z","timestamp":1780486227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"alternative-id":["S0753332222003894"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113000","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113000"}}